SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 11.60 |
| Enterprise Value ($M) | 7.89 |
| Book Value ($M) | 6.58 |
| Book Value / Share | 0.34 |
| Price / Book | 1.76 |
| NCAV ($M) | 6.29 |
| NCAV / Share | 0.32 |
| Price / NCAV | 1.84 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.08 |
| Return on Assets (ROA) | -2.46 |
| Return on Equity (ROE) | -6.84 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.24 |
| Current Ratio | 3.24 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 9.09 |
| Assets | 9.38 |
| Liabilities | 2.80 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Anson Funds Management LP | 7.10 | ||
| 13G | Ra Capital Management, L.p. | 9.90 | ||
| 13G | Perceptive Advisors Llc | 8.70 | ||
| 13G/A | Lincoln Park Capital Fund, LLC | 3.79 | -91.74 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 575,781 | 3,692,662 | 15.59 | |
| 331,140 | 1,715,447 | 19.30 | |
| 241,122 | 1,071,737 | 22.50 | |
| 387,336 | 2,197,347 | 17.63 | |
| 315,132 | 1,449,439 | 21.74 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ELTX – Elicio Therapeutics, Inc. | ELUT – Elutia Inc. |
| ENLV – Enlivex Therapeutics Ltd. | ENTO – Entero Therapeutics, Inc. |
| ENTX – Entera Bio Ltd. |
Financial data and stock pages provided by
Fintel.io